Citation 141279

NASCIMENTO,MSJ: PINTO,MMM: VIEIRA,LM: KIJJOA,A: SILVA,AMS: KROES,BH: LABADIE,RP:. (1998). ANTICOMPLEMENTARY ACTIVITY OF DOLABRANES FROM ENDOSPERMUM DIADENUM.. 8(2)

Citation Details

Title	ANTICOMPLEMENTARY ACTIVITY OF DOLABRANES FROM ENDOSPERMUM DIADENUM.
Authors	NASCIMENTO,MSJ: PINTO,MMM: VIEIRA,LM: KIJJOA,A: SILVA,AMS: KROES,BH: LABADIE,RP:
Year	1998
Volume	8
Issue	2

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Endospermum diadenum (EUPHORBIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	DOLABRAN-2-OIC ACID,2-SECO: 3-NOR: 16-CHLORO-15-HYDROXY-5-ALPHA: ENT:	None
2	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	DOLABR-3-ENE-3-15-EPSILON-DIOL,5-ALPHA: 16-CHLORO-2-OXO: ENT:	None
3	COMPLEMENT ALTERNATIVE PATHWAY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DOLABR-3-ENE-3-15-EPSILON-DIOL,5-ALPHA: 16-CHLORO-2-OXO: ENT:	INACTIVE
4	ANTICOMPLEMENT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DOLABR-3-ENE-3-15-EPSILON-DIOL,5-ALPHA: 16-CHLORO-2-OXO: ENT:	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OF	DOLABR-3-ENE-3-16-DIOL,5-ALPHA: 2-15-DIOXO: ENT:	None
6	COMPLEMENT ALTERNATIVE PATHWAY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DOLABR-3-ENE-3-16-DIOL,5-ALPHA: 2-15-DIOXO: ENT:	INACTIVE
7	ANTICOMPLEMENT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DOLABR-3-ENE-3-16-DIOL,5-ALPHA: 2-15-DIOXO: ENT:	ACTIVE
8	Not specified	ISOLATION AND IDENTIFICATION OF	DOLABR-3-EN-3-OL-15-OIC ACID,5-ALPHA: 16-NOR: 2-OXO:	None
9	COMPLEMENT ALTERNATIVE PATHWAY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DOLABR-3-EN-3-OL-15-OIC ACID,5-ALPHA: 16-NOR: 2-OXO:	INACTIVE
10	ANTICOMPLEMENT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DOLABR-3-EN-3-OL-15-OIC ACID,5-ALPHA: 16-NOR: 2-OXO:	ACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OF	DOLABR-1-4(18)-DIENE-2-16-DIOL,5-ALPHA: 3-15-DIOXO: ENT:	None
12	COMPLEMENT ALTERNATIVE PATHWAY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DOLABR-1-4(18)-DIENE-2-16-DIOL,5-ALPHA: 3-15-DIOXO: ENT:	INACTIVE
13	ANTICOMPLEMENT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DOLABR-1-4(18)-DIENE-2-16-DIOL,5-ALPHA: 3-15-DIOXO: ENT:	ACTIVE
14	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	DOLABRAN-2-OIC ACID,2-SECO: 3-NOR: 16-HYDROXY-5-ALPHA: ENT:	None
15	COMPLEMENT ALTERNATIVE PATHWAY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DOLABRAN-2-OIC ACID,2-SECO: 3-NOR: 16-HYDROXY-5-ALPHA: ENT:	INACTIVE
16	ANTICOMPLEMENT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DOLABRAN-2-OIC ACID,2-SECO: 3-NOR: 16-HYDROXY-5-ALPHA: ENT:	INACTIVE

Show SPARQL Queries (1)